Publication related to RSI or an RSI staff member

Guidelines for the communication of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop.

Biomonitoring Equivalents (BEs) are screening tools for interpreting biomonitoring data. However, the development of BEs brings to the public a relatively novel concept in the field of health risk assessment and presents new challenges for environmental risk communication. This paper provides guidance on methods for conveying information to the general public, the health care community, regulators and other interested parties regarding how chemical-specific BEs are derived, what they mean in terms of health, and the challenges and questions related to interpretation and communication of biomonitoring data. Key communication issues include: (i) developing a definition of the BE that accurately captures the BE concept in lay terms, (ii) how to compare population biomonitoring data to BEs, (iii) interpreting biomonitoring data that exceed BEs for a specific chemical, (iv) how to best describe the confidence in chemical-specific BEs, and (v) key requirements for effective communication with health care professionals. While the risk communication literature specific to biomonitoring is sparse, many of the concepts developed for traditional risk assessments apply, including transparency and discussions of confidence and uncertainty. Communication of BEs will require outreach, education, and development of communication materials specific to several audiences including the lay public and health care providers.

Authors

  • LaKind, Judy S, LaKind JS, LaKind Associates, LLC, 106 Oakdale Avenue, Catonsville, MD 21228, USA.

  • Aylward, Lesa L, Aylward LL,

  • Brunk, Conrad, Brunk C,

  • DiZio, Stephen, DiZio S,

  • Dourson, Michael, Dourson M,

  • Goldstein, Daniel A, Goldstein DA,

  • Kilpatrick, Michael E, Kilpatrick ME,

  • Krewski, Daniel, Krewski D,

  • Bartels, Michael J, Bartels MJ,

  • Barton, Hugh A, Barton HA,

  • Boogaard, Peter J, Boogaard PJ,

  • Lipscomb, John, Lipscomb J,

  • Krishnan, Kannan, Krishnan K,

  • Nordberg, Monica, Nordberg M,

  • Okino, Miles, Okino M,

  • Tan, Yu-Mei, Tan YM,

  • Viau, Claude, Viau C,

  • Yager, Janice W, Yager JW,

  • Hays, Sean M, Hays SM,

CORPORATE AUTHOR: Biomonitoring Equivalents Expert Workshop
YEAR OF PUBLICATION: 2008
SOURCE: Regul Toxicol Pharmacol. 2008 Aug;51(3 Suppl):S16-26. doi: 10.1016/j.yrtph.2008.05.007. Epub 2008 May 22.
JOURNAL TITLE ABBREVIATION: Regul Toxicol Pharmacol
JOURNAL TITLE: Regulatory toxicology and pharmacology : RTP
ISSN: 1096-0295 (Electronic) 0273-2300 (Linking)
VOLUME: 51
ISSUE: 3 Suppl
PAGES: S16-26
PLACE OF PUBLICATION: Netherlands
ABSTRACT:
Biomonitoring Equivalents (BEs) are screening tools for interpreting biomonitoring data. However, the development of BEs brings to the public a relatively novel concept in the field of health risk assessment and presents new challenges for environmental risk communication. This paper provides guidance on methods for conveying information to the general public, the health care community, regulators and other interested parties regarding how chemical-specific BEs are derived, what they mean in terms of health, and the challenges and questions related to interpretation and communication of biomonitoring data. Key communication issues include: (i) developing a definition of the BE that accurately captures the BE concept in lay terms, (ii) how to compare population biomonitoring data to BEs, (iii) interpreting biomonitoring data that exceed BEs for a specific chemical, (iv) how to best describe the confidence in chemical-specific BEs, and (v) key requirements for effective communication with health care professionals. While the risk communication literature specific to biomonitoring is sparse, many of the concepts developed for traditional risk assessments apply, including transparency and discussions of confidence and uncertainty. Communication of BEs will require outreach, education, and development of communication materials specific to several audiences including the lay public and health care providers.
LANGUAGE: eng
DATE OF PUBLICATION: 2008 Aug
DATE OF ELECTRONIC PUBLICATION: 20080522
DATE COMPLETED: 20081028
DATE REVISED: 20080728
MESH DATE: 2008/10/29 09:00
EDAT: 2008/06/27 09:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
LOCATION IDENTIFIER: 10.1016/j.yrtph.2008.05.007 [doi]
OWNER: NLM

Related RSI Experts

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski